fMRI decoded neurofeedback being tested for therapy to reduce PTSD, phobias

Jodelle Maglaya | | Health Imaging | Screening

Scientists at the ATR Computational Neuroscience Lab in Japan are using a new technique, called fMRI decoded neurofeedback (DecNef) in hopes to treat patients suffering from post-traumatic stress disorder (PTSD) and phobias. 

Data suggests that this approach is somewhat promising because it has helped patients in reducing anxieties triggered by specific memories, without asking them to think about them conciously. 

Lead researcher Mitsuo Kawato hopes that this study will become another way to treat patients. Exposure therapy accounts for a 40 percent drop-out rate amongst PTSD patients.

View full article: 

https://www.theguardian.com/science/2016/nov/21/tests-raise-hopes-for-radical-n…

Jodelle Maglaya

Jodelle joined TriMed Media Group in 2016 as a senior writer, focusing on content for Radiology Business and Health Imaging. After receiving her master's from DePaul University, she worked as a news reporter and communications specialist.

Related Content

What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Breast cancer rates among women in their 30s are on the rise
Singing radiologist pens song to clear up confusion about breast cancer screening recs
AI loaded onto mammography systems can flag possible cancers in real time to speed workflows

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.